SAN JOSE, Calif.--(BUSINESS WIRE)--Vital Connect announced today that its FDA-cleared wearable biosensor, HealthPatch® MD, is now available for use in clinical trials in partnership with Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences. HealthPatch® MD can be used with Medidata’s industry-leading technology platform (Medidata Clinical Cloud®) and its mobile app for patient-reported outcomes (Medidata Patient Cloud®) to further remote patient monitoring, which has the potential to make clinical trials more efficient.
When deployed with the Medidata Clinical Cloud, HealthPatch® MD comprehensively collects large volumes of objective data that is reliable, secure and analysis-ready. By providing continuous insight into patient health metrics in near-real time, the combined technologies can enable faster, more patient-centric clinical research, while ensuring compliance and data quality.
Help employers find you! Check out all the jobs and post your resume.
When deployed with the Medidata Clinical Cloud, HealthPatch® MD comprehensively collects large volumes of objective data that is reliable, secure and analysis-ready. By providing continuous insight into patient health metrics in near-real time, the combined technologies can enable faster, more patient-centric clinical research, while ensuring compliance and data quality.
Help employers find you! Check out all the jobs and post your resume.
